PMC:7324763 / 45733-45892 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T569","span":{"begin":11,"end":13},"obj":"Body_part"}],"attributes":[{"id":"A569","pred":"fma_id","subj":"T569","obj":"http://purl.org/sig/ont/fma/fma86578"}],"text":"      Anti IL-1R/Anti IFNγ Anakinra vs. Emapalumab NCT04324021 II/III Italy (4) 54 Pneumatic COVID19+ Anakinra (IL1r antagonist); Emapalumab (anti-IFNγ)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T345","span":{"begin":99,"end":106},"obj":"Disease"}],"attributes":[{"id":"A345","pred":"mondo_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"      Anti IL-1R/Anti IFNγ Anakinra vs. Emapalumab NCT04324021 II/III Italy (4) 54 Pneumatic COVID19+ Anakinra (IL1r antagonist); Emapalumab (anti-IFNγ)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T256","span":{"begin":11,"end":13},"obj":"Chemical"},{"id":"T258","span":{"begin":66,"end":68},"obj":"Chemical"},{"id":"T259","span":{"begin":124,"end":134},"obj":"Chemical"}],"attributes":[{"id":"A256","pred":"chebi_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A257","pred":"chebi_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A258","pred":"chebi_id","subj":"T258","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A259","pred":"chebi_id","subj":"T259","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"}],"text":"      Anti IL-1R/Anti IFNγ Anakinra vs. Emapalumab NCT04324021 II/III Italy (4) 54 Pneumatic COVID19+ Anakinra (IL1r antagonist); Emapalumab (anti-IFNγ)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1333","span":{"begin":11,"end":16},"obj":"Gene"},{"id":"1334","span":{"begin":22,"end":26},"obj":"Gene"},{"id":"1335","span":{"begin":119,"end":123},"obj":"Gene"},{"id":"1336","span":{"begin":154,"end":158},"obj":"Gene"},{"id":"1371","span":{"begin":89,"end":117},"obj":"Disease"}],"attributes":[{"id":"A1333","pred":"tao:has_database_id","subj":"1333","obj":"Gene:3554"},{"id":"A1334","pred":"tao:has_database_id","subj":"1334","obj":"Gene:3458"},{"id":"A1335","pred":"tao:has_database_id","subj":"1335","obj":"Gene:3554"},{"id":"A1336","pred":"tao:has_database_id","subj":"1336","obj":"Gene:3458"},{"id":"A1371","pred":"tao:has_database_id","subj":"1371","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"      Anti IL-1R/Anti IFNγ Anakinra vs. Emapalumab NCT04324021 II/III Italy (4) 54 Pneumatic COVID19+ Anakinra (IL1r antagonist); Emapalumab (anti-IFNγ)"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T137","span":{"begin":11,"end":16},"obj":"http://purl.obolibrary.org/obo/GO_0004908"}],"text":"      Anti IL-1R/Anti IFNγ Anakinra vs. Emapalumab NCT04324021 II/III Italy (4) 54 Pneumatic COVID19+ Anakinra (IL1r antagonist); Emapalumab (anti-IFNγ)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T283","span":{"begin":0,"end":159},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"      Anti IL-1R/Anti IFNγ Anakinra vs. Emapalumab NCT04324021 II/III Italy (4) 54 Pneumatic COVID19+ Anakinra (IL1r antagonist); Emapalumab (anti-IFNγ)"}